Solvonis Therapeutics (SVNS)

Sector:

Pharma and Biotech

0.24p
   
  • Change Today:
    -0.020p
  • 52 Week High: 0.39
  • 52 Week Low: 0.13
  • Currency: UK Pounds
  • Shares Issued: 6,806m
  • Volume: 12,855,301
  • Market Cap: £16.34m
  • Beta: 0.02

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Nicholas Nelson 167,500,000 £402,000

Major Shareholders

Notifier** Holding Value*
WILLIAM POTTS 610,461,538 £1,465,108
Spreadex Ltd 205,961,538 £494,308
Nicholas Christian Paul Nelson 205,961,538 £494,308
Stuart Sharpless 196,351,963 £471,245
Steven Myers 117,500,000 £282,000
Paul Levinson 75,000,000 £180,000
Victor Bolduev 30,454,612 £73,091
Alba Capital Pty Ltd 13,935,020 £33,444
Brett Michell 7,869,217 £18,886
Platypus Assets Pty Ltd 6,250,000 £15,000
Premier Miton 6,050,000 £14,520
Roby Zomer 5,451,337 £13,083
Freya Holding Limited 4,576,163 £10,983
William Murray Mitchell, Diane Joan Mitchell 4,084,459 £9,803

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

SVNS Market Data

Currency UK Pounds
Share Price 0.24p
Change Today -0.020p
% Change -7.69 %
52 Week High 0.39
52 Week Low 0.13
Volume 12,855,301
Shares Issued 6,806m
Market Cap £16.34m
Beta 0.02

SVNS Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
44.84% below the market average44.84% below the market average44.84% below the market average44.84% below the market average44.84% below the market average
2.44% above the sector average2.44% above the sector average2.44% above the sector average2.44% above the sector average2.44% above the sector average
Price Trend
35.55% above the market average35.55% above the market average35.55% above the market average35.55% above the market average35.55% above the market average
40.91% above the sector average40.91% above the sector average40.91% above the sector average40.91% above the sector average40.91% above the sector average
Income Not Available
Growth Not Available

SVNS Dividends

No dividends found

Trades for 28-May-2026

Time Volume / Share Price
16:35 100 @ 0.24p
16:35 100 @ 0.24p
16:00 3,000 @ 0.26p
15:30 3,174 @ 0.26p
14:00 880,000 @ 0.25p

SVNS Key Personnel

CEO Anthony Tennyson
Chair Dennis Purcell

Top of Page